Mechanisms accounting for the favorable prognosis may include increased tumor infiltration of CD8+ T cells, more effector T cells than Tregs in systemic circulation, dendritic cell function, IL-12 secretion, anabolic metabolism, and systemic inflammation (271–273), but the mechanistic links for these immunomodulatory effects remain unknown. This evidence concerns the gene CD8A and neoplasm.